Categories
Lupin Limited — Updates, 22-04-2026: Press Release
22-04-2026 · 09:13 am
Lupin launched Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US. This US FDA approved generic equivalent to Xigduo® XR strengthens the company's anti-diabetic portfolio in a key market.
No comments yet. Be the first to comment!